CSR Wire

Elanco’s Credelio™ (Lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) Against New World Screwworm (NWS) in Dogs

First FDA emergency use authorization (EUA) ever granted for NWS in dogs Action reinforces agency’s commitment to providing treatment options for NWS in advance of the fly being detected in the U.S.
Seeking Alpha

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection ...

GREENFIELD, Ind., Oct. 7, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Credelio Quattro™ (lotilaner, ...